Tactile Systems Technology, Inc. (TCMD) announced on Wednesday the successful achievement of disease-specific health-related quality of life endpoints in a study evaluating the use of the Flexitouch advanced pneumatic compression device for veterans with lower extremity lymphedema.
This 52-week study has been published in the Journal of Vascular Surgery: Venous and Lymphatic Disorders.
Additionally, the study's secondary outcome measures included assessments of limb circumference, frequency of cellulitis events, skin quality, and therapy compliance over the 52-week period.
